O07.1

Clinical Causes: Incomplete uterine evacuation leading to bleeding Complications related to blood clotting disorders (e.g., afibrinogenemia, disseminated intravascular coagulation) Retained products of conception Vascular injury during the termination procedure Underlying coagulopathies or bleeding disorders Infections causing inflammation and bleeding

Key Symptoms: Prolonged or heavy vaginal bleeding Bleeding that occurs some days after the initial procedure Signs of anemia such as fatigue, weakness, or dizziness Pelvic pain or cramping Signs of systemic bleeding or clotting issues, such as easy bruising or bleeding from other sites Tissue or clots passed from the vagina

Diagnosis Path: Diagnosis involves clinical evaluation and a combination of laboratory tests, including: - Complete blood count (CBC) to assess anemia - Coagulation profile, including fibrinogen levels and D-dimer - Blood smear analysis to detect hemolysis - Imaging studies like ultrasound to evaluate retained tissue or bleeding sources - Specific tests for bleeding disorders, if indicated Doctors may also review medical history and previous pregnancy attempts to identify underlying risk factors.

Treatment Protocols: Management strategies focus on controlling bleeding and addressing any underlying coagulopathies. Approaches include: - Stabilization of the patient with fluids and blood transfusions if necessary - Administration of clotting factors, such as fibrinogen, in cases of coagulopathies - Medications that promote uterine contraction to help reduce bleeding - Use of surgical interventions such as curettage or dilation and curettage (D&C) if retained tissue is present - Monitoring and managing complications like anemia or infection - Long-term treatment for any diagnosed bleeding or clotting disorders It is essential for treatment to be tailored to the patient's specific condition and underlying causes.